Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Aptuit Secures Additional Private Equity Funding, Bringing Potential Capital Available to More Than $750 Million.


GREENWICH, Conn. -- Temasek Holdings Temasek Holdings is an Asia investment company headquartered in Singapore. With a multinational staff of more than 300 people, it manages a portfolio of over S$160 billion, or more than US$100 billion, focused primarily in Asia.  Makes Minority Investment, Adds John Nine to Aptuit's Board of Directors

Aptuit, Inc. announced today that it has secured additional funding to aid the company in its ongoing efforts to build an industry-leading drug development services organization. Temasek Holdings Limited joined Welsh, Carson, Anderson & Stowe (WCAS WCAS Weinberg College of Arts and Sciences
WCAS Warfighter Communication Assessment System (US DoD) 
), Aptuit's lead investor, with a minority investment, bringing the potential capital available to more than $750 million. Aptuit also announced today the addition of John E. Nine, former Schering-Plough executive and current corporate advisor to Temasek, to its board of directors.

"We founded Aptuit with the goal of engineering a better drug development process and are well on our way to realizing our vision for the industry with three significant acquisitions under our belt," noted Michael A. Griffith, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Aptuit. "This latest investment from Temasek is a validation of our progress thus far and an endorsement for our future growth plans. We are working to add active pharmaceutical ingredient development and manufacturing capabilities and are seeking to make supplemental investments to deepen deep·en  
tr. & intr.v. deep·ened, deep·en·ing, deep·ens
To make or become deep or deeper.


deepen
Verb

to make or become deeper or more intense

Verb 1.
 our current business lines, thus rounding out our service offering for customers."

Mr. Griffith continued by saying, "Through this investment, we are also pleased to add John Nine to our board of directors. John's experience working with top-tier pharmaceutical companies in the production and manufacturing of therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
 is an invaluable addition to our already strong board of directors."

Mr. Nine noted, "Aptuit's vision and business model for a drug development services company are unique in the industry with a focus towards horizontal integrated management across all facets of the drug development continuum. The leadership at Aptuit has a strong history and track record of building similar, highly successful companies through acquisitions and investment. I look forward to working with the rest of the Board and management to contribute towards Aptuit's global expansion plans."

In addition to Michael A. Griffith and today's appointment of John Nine, the Aptuit board of directors consists of three members from WCAS.

About Temasek Holdings:

Temasek Holdings is an Asia investment company headquartered in Singapore. Established in 1974, it manages a diversified diversified (di·verˑ·s  global portfolio of US $63 billion, spanning Singapore, Asia and the OECD OECD: see Organization for Economic Cooperation and Development.  economies. Its investments are in various industries including telecommunications and media, financial services The examples and perspective in this article or section may not represent a worldwide view of the subject.
Please [ improve this article] or discuss the issue on the talk page.
, property, transportation and logistics, energy and resources, infrastructure, engineering and technology, as well as pharmaceuticals and biosciences. For more information, please visit www.temasekholdings.com.sg.

About Welsh, Carson, Anderson & Stowe:

Welsh, Carson, Anderson & Stowe (WCAS) is one of the largest private equity investment firms in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , and is the largest in the world focused exclusively on healthcare and information & business services. Since its founding in 1979, WCAS has organized 14 limited partnerships with total capital over $15 billion. Over that time, the company has invested in more than 135 companies and has funded over 650 follow-on acquisitions. For more information, please visit www.welshcarson.com.

About Aptuit:

Aptuit, Inc. is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators innovators

people who will try new things.


early innovators
important figures in the farming or client community because they are the leaders in the introduction of new techniques and management systems.
. The company was founded by a group of industry experts with extensive market experience who have a track record of building a similar, highly successful company through acquisitions and investment. Aptuit will provide a comprehensive suite of product development services and competencies to biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
 and large, fully integrated pharmaceutical companies worldwide. Aptuit's mission is to engineer a better drug development process, and is partnered with Welsh, Carson, Anderson & Stowe, one of the world's largest private equity investors. For more information about Aptuit, please visit www.aptuit.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company overview
Date:Apr 10, 2006
Words:592
Previous Article:TargetRx CEO Wins Philadelphia Business Journal's 40 Under 40 Award; Mike Luby Honored for Outstanding Contributions to Pharmaceutical Industry and...
Next Article:Accenture and Unilever Sign European Information Technology Outsourcing Contract.
Topics:



Related Articles
Ellis takes itself private.
Aptuit, Inc. Completes Acquisition of Almedica International; Deal Close Marks Another Milestone in Company's Vision to Engineer a Better Drug...
Aptuit Completes InfoPro Solutions Acquisition, Launches Informatics Business Line.
Aptuit Appoints Stuart Needleman Senior Director, Active Pharmaceutical Ingredient Development.
Aptuit Names Vito Saccente Senior Director, Sales for North America; Strategic Hire Strengthens Company's Sales Force and U.S. Presence.
John Fikre Joins Aptuit, Inc. as Vice President, General Counsel; Contributes Extensive Experience in Mergers and Acquisitions, Joint Ventures, and...
Peter J. Adamski Joins Aptuit as Chief Financial Officer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles